shortagewatch

Home / Cancer and immune system / Plerixafor

ATC L03AX16 · Immunostimulants

Plerixafor shortage

As of 31 Oct 2026, Plerixafor has a reported shortage in 3 of the 5 countries we track (Germany, Austria, Belgium), covering 3 products.

Countries3/5
Products3packs or presentations
Short since17 Mar 20268 months ago
Earliest return16 Nov 2026company estimate
No return date0products
Main reasonIncreased demand
Germany1 pack shortItalyNo reported shortageSpainNo reported shortageAustria1 pack shortBelgium1 pack short

Timeline

GermanyAustriaBelgium
2027Plerixafor Viatris 20 mg/ml InjektionslösungPlerixafor Viatris 20 mg/ml InjektionslösungPlerixafor Viatris 20 mg/ml InjektionslösungPlerixafor Viatris 20 mg/ml Injektionslösung, 1 StückPlerixafor Accord 20 mg/ml inj. sol. s.c. viPlerixafor Accord 20 mg/ml inj. sol. s.c. vial 1.2 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEPlerixafor Viatris 20 mg/ml InjektionslösungViatris Germany GmbH15 Jul 202631 Dec 2026Increased demand
Erhöhte Nachfrage
ATPlerixafor Viatris 20 mg/ml Injektionslösung, 1 StückViatris Limited8 Oct 202620 Nov 2026Increased demand
Erhöhter Mehrbedarf
BEPlerixafor Accord 20 mg/ml inj. sol. s.c. vial 1.2 mlAccord Healthcare17 Mar 202616 Nov 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Bcg Vaccine